Age-related changes in the glycation of human aortic elastin

被引:95
作者
Konova, E
Baydanoff, S
Atanasova, M
Velkova, A
机构
[1] Univ Sch Med, Ctr Clin Immunol, Pleven 5800, Bulgaria
[2] Univ Sch Med, Dept Biol, Pleven, Bulgaria
[3] Univ Sch Med, Dept Social Med & Hlth Management, Pleven, Bulgaria
关键词
elastin; non-enzymatic glycation; fructosamine; advanced glycation end products; aging;
D O I
10.1016/j.exger.2003.10.003
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Non-enzymatic glycation of proteins is a consequence of hyperglycemia in diabetes and correlates with aging. The aim of the study was to investigate age-related changes in the glycation of human aortic elastin in healthy subjects by two approaches: (1) assessment by fluorescence method of formed in vivo advanced glycation end products (AGEs) of elastins, purified from human aortas, obtained from different age groups;, (2) in vitro glycation of elastins from different age groups and investigation of their capacity to form early (by colorimetric nitroblue tetrazolium method) and AGEs (fluorescence method). Human insoluble elastins were prepared from macro- and microscopic unaltered regions of thoracic aortas, obtained from 68 accident victims, distributed in 15 age-groups, using the method of Starcher and Galione. Soluble alpha-elastins were obtained by the method of Partridge et al. The direct assessment of Maillard reaction related fluorescence in the age groups showed increase of the fluorescence with age. The 'young' elastin had the highest capacity to form both fructosamine and AGEs under glycation of 'old' elastin did not increase markedly during the incubation. These results are consistent with the glycation in vitro. The interpretation that because of its long biological half-life, elastin is susceptible to the slow process of glycation and the following modifications would contribute to the age-related changes of connective tissue. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 34 条
[1]   Determination of anti-AGE antibodies in human serum [J].
Baydanoff, S ;
Konova, E ;
Ivanova, N .
GLYCOCONJUGATE JOURNAL, 1996, 13 (03) :335-339
[2]  
Baydanoff S., 1994, GLYCOSYLATION DIS, V1, P53, DOI DOI 10.1007/BF00917469
[3]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[4]   Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age [J].
Bruel, A ;
Oxlund, H .
ATHEROSCLEROSIS, 1996, 127 (02) :155-165
[5]  
BUCALA R, 1992, POSTTRANSLATIONAL MO, P53
[6]  
BUNN HF, 1979, J BIOL CHEM, V254, P3892
[7]  
CERAMI A, 1985, J AM GERIATR SOC, V33, P624
[8]  
EBLE AS, 1983, J BIOL CHEM, V258, P9406
[9]  
HORII Y, 1992, DIABETES, V41, pA59
[10]  
JOHNSON RN, 1982, CLIN CHIM ACTA, V127, P87